Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Holy

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Molecular Pharmacology|November 1, 2015
Binding Mode Selection Determines the Action of Ecstasy Homologs at Monoamine TransportersWalter Sandtner, Thomas Stockner, Peter S Hasenhuetl, et al.
Journal of Neurochemistry|April 24, 2025
Careful Examination of a Novel Azobenzene Paroxetine Derivative and Its Interactions With Biogenic Amine TransportersDominik Dreier, Oliver John V Belleza, Katharina Schlögl, et al.
Nature Communications|November 7, 2022
Structural basis of organic cation transporter-3 inhibitionBasavraj Khanppnavar, Julian Maier, Freja Herborg, et al.
Neuron|August 16, 2006
Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transportJacob U Fog, Habibeh Khoshbouei, Marion Holy, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 9, 2021
(2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in miceDeborah Rudin, John D McCorvy, Grant C Glatfelter, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 18, 2012
Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' productsMichael H Baumann, John S Partilla, Kurt R Lehner, et al.
Angewandte Chemie (International Ed. in English)|December 24, 2015
Nanopharmacological Force Sensing to Reveal Allosteric Coupling in Transporter Binding SitesRong Zhu, Doris Sinwel, Peter S Hasenhuetl, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2013
Amphetamine actions at the serotonin transporter rely on the availability of phosphatidylinositol-4,5-bisphosphateFlorian Buchmayer, Klaus Schicker, Thomas Steinkellner, et al.
ACS Chemical Neuroscience|December 2, 2025
Next-Generation MDMA Analogue SDMA: Pharmacological and Metabolic InsightsNina Kastner, Núria Nadal-Gratacós, Selina Hemmer, et al.
Molecular Psychiatry|November 9, 2022
Serotonin-releasing agents with reduced off-target effectsFelix P Mayer, Marco Niello, Daniela Cintulova, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Molecular Pharmacology|November 1, 2015
Binding Mode Selection Determines the Action of Ecstasy Homologs at Monoamine TransportersWalter Sandtner, Thomas Stockner, Peter S Hasenhuetl, et al.
Journal of Neurochemistry|April 24, 2025
Careful Examination of a Novel Azobenzene Paroxetine Derivative and Its Interactions With Biogenic Amine TransportersDominik Dreier, Oliver John V Belleza, Katharina Schlögl, et al.
Nature Communications|November 7, 2022
Structural basis of organic cation transporter-3 inhibitionBasavraj Khanppnavar, Julian Maier, Freja Herborg, et al.
Neuron|August 16, 2006
Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transportJacob U Fog, Habibeh Khoshbouei, Marion Holy, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 9, 2021
(2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in miceDeborah Rudin, John D McCorvy, Grant C Glatfelter, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 18, 2012
Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' productsMichael H Baumann, John S Partilla, Kurt R Lehner, et al.
Angewandte Chemie (International Ed. in English)|December 24, 2015
Nanopharmacological Force Sensing to Reveal Allosteric Coupling in Transporter Binding SitesRong Zhu, Doris Sinwel, Peter S Hasenhuetl, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2013
Amphetamine actions at the serotonin transporter rely on the availability of phosphatidylinositol-4,5-bisphosphateFlorian Buchmayer, Klaus Schicker, Thomas Steinkellner, et al.
ACS Chemical Neuroscience|December 2, 2025
Next-Generation MDMA Analogue SDMA: Pharmacological and Metabolic InsightsNina Kastner, Núria Nadal-Gratacós, Selina Hemmer, et al.
Molecular Psychiatry|November 9, 2022
Serotonin-releasing agents with reduced off-target effectsFelix P Mayer, Marco Niello, Daniela Cintulova, et al.
Pageof 6